These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 1462067)
1. [What is your diagnosis? Acute intermittent porphyria]. Marty H Schweiz Rundsch Med Prax; 1992 Dec; 81(49):1471-2. PubMed ID: 1462067 [No Abstract] [Full Text] [Related]
2. [Porphyrins and their precursors in the urine of patients with suspected porphyria; a 16-year experience]. Zawirska B; Kwiatkowska W; Nowojska A Pol Tyg Lek; 1985 Jan; 40(4):97-100. PubMed ID: 3983004 [No Abstract] [Full Text] [Related]
3. [Urinary excretion of porphyrins and their precursors. Longterm observations in acute intermittent porphyrias (author's transl)]. Brugsch J; Müller H MMW Munch Med Wochenschr; 1979 Mar; 121(13):457-8. PubMed ID: 107424 [TBL] [Abstract][Full Text] [Related]
4. [Pathophysiology and diagnosis of acute intermittent porphyria]. Wichmann T; Freye HA Z Gesamte Inn Med; 1977 Jun; 32(12):289-92. PubMed ID: 910533 [TBL] [Abstract][Full Text] [Related]
9. Acute intermittent porphyria. Day RS; Eales L S Afr Med J; 1982 Feb; 61(8):260-1. PubMed ID: 7058452 [No Abstract] [Full Text] [Related]
10. [Genetic prognosis of a mother with acute intermittent porphyria (hepatic form)]. Pfändler U J Genet Hum; 1974 Jun; 22(2):185-7. PubMed ID: 4420375 [No Abstract] [Full Text] [Related]
11. [Diagnostic and therapeutic problems in acute intermittent porphyria]. Mühler E Nervenarzt; 1976 Feb; 47(2):126-9. PubMed ID: 1256621 [No Abstract] [Full Text] [Related]
12. Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria. Marsden JT; Rees DC J Clin Pathol; 2014 Jan; 67(1):60-5. PubMed ID: 23908454 [TBL] [Abstract][Full Text] [Related]
13. Elevated porphyrins following propofol anaesthesia in acute intermittent porphyria. Elcock D; Norris A Anaesthesia; 1994 Nov; 49(11):957-8. PubMed ID: 7802240 [TBL] [Abstract][Full Text] [Related]
14. Safe usage of isotretinoin in a woman with latent acute intermittent porphyria. Storjord E; Brekke OL; Nielsen EW Acta Derm Venereol; 2007; 87(3):267-8. PubMed ID: 17533497 [No Abstract] [Full Text] [Related]
15. Use of transcutaneous nerve stimulation in the attacks of acute intermittent porphyria. Kaada B; Romslo I Int J Biochem; 1985; 17(2):235-40. PubMed ID: 3874101 [TBL] [Abstract][Full Text] [Related]
16. [The effect of bloodletting on the excretion of porphyrius and clelta aminolevulinic acid as well as the clinical picture of porphyria cutanea tarda]. Broese I; Mattheus A Dermatol Monatsschr; 1977 Feb; 163(2):111-8. PubMed ID: 858437 [No Abstract] [Full Text] [Related]
17. [Diagnosis of acute porphyria]. Mustajoki P; Kauppinen R Duodecim; 1986; 102(17):1218-21. PubMed ID: 3769820 [No Abstract] [Full Text] [Related]
18. [On the excretion of 5-aminolevulinic acid and porphobilinogen in latent porphyria]. KELENYI G; ARATO G; BUDA V; ORBAN S Folia Haematol Int Mag Klin Morphol Blutforsch; 1961; 78():205-13. PubMed ID: 14454906 [No Abstract] [Full Text] [Related]
19. Acute intermittent porphyria--another approach to therapy. Wider de Xifra EA; Batlle AM; Stella AM; Malamud S Int J Biochem; 1980; 12(5-6):819-22. PubMed ID: 7450138 [No Abstract] [Full Text] [Related]
20. The hepatic porphyrias. Romeo G Prog Med Genet; 1980; 4():169-97. PubMed ID: 7003654 [No Abstract] [Full Text] [Related] [Next] [New Search]